Computers in Biology and Medicine · Jan 2025
A 2025 paper reported prospective clinical results from Oncobox-guided RNA sequencing analysis in 239 adult solid cancer patients, with signal for improved progression-free survival in a subset analysis.
Finding the right cancer drug for each patient.
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Oncobox (also appearing in some public directories as OmicsWay Corp. or OncoBox) is a precision oncology diagnostics company that uses tumor DNA/RNA profiling, pathway scoring, and bioinformatics/AI to rank targeted and immunotherapy drugs for individual cancer patients. Public sources disagree on size and headquarters; the current LinkedIn company page says San Francisco and about 1 employee, while older directories list Walnut/Los Angeles and larger counts.
Primary product
Oncobox Dx
Founded
2015
Headquarters
San Francisco, California, United States (older directories also list Walnut, CA)
Team size
1-10
Industry
Medical and Diagnostic Laboratories
Sub-industry
Precision oncology diagnostics / molecular diagnostics
Offices
Open Positions
0 jobs at Oncobox
No open positions
Check back later for new openings